JP7253866B1
(ja )
2023-04-07
トリアジン誘導体を含有する経口投与する製剤
US8227463B2
(en )
2012-07-24
Amorphous body composed of heterocyclic compound, solid dispersion and pharmaceutical preparation each comprising the same, and process for production of the same
AU2014283231B2
(en )
2017-12-07
Amorphous Letermovir and solid pharmaceutical formulations thereof for oral administration
US20120035142A1
(en )
2012-02-09
Polymorphs of darunavir
EP2238979A1
(en )
2010-10-13
Active pharmaceutical ingredient adsorbed on solid support
US7625911B2
(en )
2009-12-01
Amorphous form of erlotinib hydrochloride and its solid amorphous dispersion
US9453024B2
(en )
2016-09-27
Polymorphs of darunavir
CN117255680A
(zh )
2023-12-19
含有三嗪衍生物的口服给与的制剂
CN113490492A
(zh )
2021-10-08
吡唑酰胺化合物的非晶质固体分散体
US11236073B2
(en )
2022-02-01
ODM-201 crystalline form, preparation method therefor, and pharmaceutical composition thereof
EP3887356B1
(en )
2023-08-02
Multi-component crystals of an orally available hif prolyl hydroxylase inhibitor
EP2295038B1
(en )
2013-05-29
Solid dispersion comprising an anti-HIV agent
CN107602546A
(zh )
2018-01-19
化合物的晶型及其制备方法、组合物和应用
WO2001097853A1
(en )
2001-12-27
Improvement of itraconazole bioavailability
CA2952627C
(en )
2018-05-22
Anhydrous crystalline free base form of 6-{2-[1-(6-methyl-3-pyridazinyl)-4-piperidinyl]ethoxy}-3-ethoxy-1,2-benzisoxazole
HK1154792A
(zh )
2012-05-04
包括一个抗hiv媒体的固态分散体
US20180064714A1
(en )
2018-03-08
Process for the Preparation of Amorphous Idelalisib and its Premix
KR102684499B1
(ko )
2024-07-11
메벤다졸 함유 고체 분산체, 이를 포함하는 약제학적 조성물 및 이의 제조방법
EP3653629A1
(en )
2020-05-20
Acid addition salts of an integrase strand transfer inhibitor
HK1223935B
(zh )
2020-05-15
无定形莱特莫韦及其用於口服施用的固体药物制剂